APA

Braun Hashemi C. A., Zang Y. C. Q., Arbona J. A., Bauerle J. A., Frazer M. L., Lee H., Flury L., Moore E. S., Kolar M. C., Washington R. Y. & Kolar O. J. (20061212). Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone and azathioprine. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Braun Hashemi C A, Zang Y C Q, Arbona J A, Bauerle J A, Frazer M L, Lee H, Flury L, Moore E S, Kolar M C, Washington R Y and Kolar O J. 20061212. Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone and azathioprine. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Braun Hashemi C. A., Zang Y. C. Q., Arbona J. A., Bauerle J. A., Frazer M. L., Lee H., Flury L., Moore E. S., Kolar M. C., Washington R. Y. and Kolar O. J. (20061212). Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone and azathioprine. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Braun Hashemi C A, Zang Y C Q, Arbona J A, Bauerle J A, Frazer M L, Lee H, Flury L, Moore E S, Kolar M C, Washington R Y and Kolar O J. Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone and azathioprine. : Multiple sclerosis (Houndmills, Basingstoke, England). 20061212.